Royal Bank of Canada’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.7M | Buy |
263,809
+259,142
| +5,553% | +$3.63M | ﹤0.01% | 2570 |
|
|
2025
Q1 | $73K | Buy |
4,667
+1,828
| +64% | +$28.6K | ﹤0.01% | 5036 |
|
|
2024
Q4 | $40K | Sell |
2,839
-9,407
| -77% | -$133K | ﹤0.01% | 5298 |
|
|
2024
Q3 | $113K | Sell |
12,246
-407
| -3% | -$3.76K | ﹤0.01% | 4811 |
|
|
2024
Q2 | $118K | Buy |
12,653
+9,558
| +309% | +$89.1K | ﹤0.01% | 4778 |
|
|
2024
Q1 | $31K | Sell |
3,095
-17,999
| -85% | -$180K | ﹤0.01% | 5279 |
|
|
2023
Q4 | $68K | Buy |
21,094
+13,616
| +182% | +$43.9K | ﹤0.01% | 5305 |
|
|
2023
Q3 | $39K | Buy |
7,478
+3,006
| +67% | +$15.7K | ﹤0.01% | 5414 |
|
|
2023
Q2 | $42K | Buy |
4,472
+1,118
| +33% | +$10.5K | ﹤0.01% | 5400 |
|
|
2023
Q1 | $37K | Sell |
3,354
-3,124
| -48% | -$34.5K | ﹤0.01% | 5388 |
|
|
2022
Q4 | $96K | Buy |
6,478
+5,349
| +474% | +$79.3K | ﹤0.01% | 5013 |
|
|
2022
Q3 | $21K | Buy |
1,129
+477
| +73% | +$8.87K | ﹤0.01% | 5619 |
|
|
2022
Q2 | $14K | Sell |
652
-1,248
| -66% | -$26.8K | ﹤0.01% | 5768 |
|
|
2022
Q1 | $37K | Sell |
1,900
-3,207
| -63% | -$62.5K | ﹤0.01% | 5783 |
|
|
2021
Q4 | $106K | Buy |
5,107
+2,467
| +93% | +$51.2K | ﹤0.01% | 5358 |
|
|
2021
Q3 | $63K | Buy |
2,640
+587
| +29% | +$14K | ﹤0.01% | 5501 |
|
|
2021
Q2 | $56K | Buy |
2,053
+768
| +60% | +$20.9K | ﹤0.01% | 5461 |
|
|
2021
Q1 | $37K | Buy |
1,285
+962
| +298% | +$27.7K | ﹤0.01% | 5567 |
|
|
2020
Q4 | $9K | Buy |
323
+304
| +1,600% | +$8.47K | ﹤0.01% | 5854 |
|
|
2020
Q3 | $1K | Buy |
19
+2
| +12% | +$105 | ﹤0.01% | 5890 |
|
|
2020
Q2 | $1K | Sell |
17
-540
| -97% | -$31.8K | ﹤0.01% | 5898 |
|
|
2020
Q1 | $16K | Buy |
+557
| New | +$16K | ﹤0.01% | 5128 |
|